Related Experiment Video

Updated: Jun 19, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Apoptomirs: small molecules have gained the license to kill

Andrea Vecchione1, Carlo M Croce

  • 1Human Cancer Genetics Program, Division of Pathology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43216, USA. andrea.vecchione@uniroma1.it

Endocrine-Related Cancer
|October 10, 2009
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of apoptosis, a crucial process in cell death and cancer development. Understanding miRNA roles in apoptosis can improve cancer treatment sensitivity and patient outcomes.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Apoptosis is a regulated cell death process vital for development and cancer biology.
  • MicroRNAs (miRNAs) are non-coding RNAs influencing diverse biological processes, including apoptosis.
  • Dysregulation of apoptosis is implicated in cancer development and treatment resistance.

Purpose of the Study:

  • To review current findings on microRNAs and their involvement in the apoptotic process.
  • To highlight the role of miRNAs in modulating cancer cell sensitivity to therapy.
  • To emphasize the need for further investigation into miRNA functions and targets for improved cancer treatment.

Main Methods:

  • Literature review of scientific studies on microRNAs and apoptosis.
  • Analysis of research linking microRNA functions to apoptotic pathways.
  • Synthesis of evidence regarding miRNA involvement in cancer treatment resistance.

Main Results:

  • MicroRNAs play significant roles in regulating apoptosis.
  • MiRNAs are implicated in modulating sensitivity and resistance to cytotoxic cancer therapies.
  • Defects in apoptotic pathways, potentially involving miRNAs, can lead to treatment failure.

Conclusions:

  • MicroRNAs are critical regulators of apoptosis with implications for cancer.
  • Targeting miRNAs may offer strategies to enhance cancer treatment efficacy.
  • Further research on miRNA-apoptosis interactions is essential for improving cancer patient prognosis and survival.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...